Synovis Life Technologies, Inc. (Nasdaq: SYNO), a diversified medical device company, will present at the UBS 2009 Global Life Sciences Conference at 4 p.m. ET on Monday, Sept. 21, 2009,at the Grand Hyatt New York. Richard W. Kramp, president and chief executive officer, and Brett A. Reynolds, chief financial officer, will discuss the company’s recent performance and market opportunities.

After the presentation, the slides will be posted on the company’s Web site and will be available for approximately two weeks.

About Synovis Life Technologies
Synovis Life Technologies, Inc., based in St. Paul, Minn., is a diversified medical device company that develops, manufactures and markets medical devices for the surgical treatment of disease. The company’s products include implantable biomaterials for soft tissue repair, devices for microsurgery and surgical tools - all designed to reduce risks and/or facilitate critical surgeries, improve patient outcomes and reduce healthcare costs. For additional information on Synovis Life Technologies and its products, visit the company’s Web site at www.synovislife.com.

Contacts:

Padilla Speer Beardsley Inc.
Nancy A. Johnson, 612-455-1745
or
Marian Briggs, 612-455-1742
or
Synovis Life Technologies, Inc.
Brett Reynolds, CFO, 651-796-7300